SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 29 filers reported holding SIERRA ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,778,000 | -12.3% | 8,112,121 | 0.0% | 0.47% | -52.9% |
| Q3 2019 | $3,168,000 | -30.3% | 8,112,121 | 0.0% | 0.99% | -14.9% |
| Q2 2019 | $4,543,000 | -67.3% | 8,112,121 | 0.0% | 1.16% | -65.1% |
| Q1 2019 | $13,872,000 | +29.5% | 8,112,121 | 0.0% | 3.34% | +20.8% |
| Q4 2018 | $10,708,000 | -22.4% | 8,112,121 | 0.0% | 2.76% | +9.4% |
| Q3 2018 | $13,791,000 | -42.6% | 8,112,121 | 0.0% | 2.52% | -49.2% |
| Q2 2018 | $24,012,000 | +43.0% | 8,112,121 | 0.0% | 4.97% | +78.5% |
| Q1 2018 | $16,792,000 | -44.5% | 8,112,121 | 0.0% | 2.79% | -43.2% |
| Q4 2017 | $30,258,000 | +140.6% | 8,112,121 | 0.0% | 4.91% | +9.4% |
| Q3 2017 | $12,574,000 | +32.5% | 8,112,121 | 0.0% | 4.48% | -7.8% |
| Q2 2017 | $9,491,000 | -23.5% | 8,112,121 | 0.0% | 4.86% | -26.6% |
| Q1 2017 | $12,412,000 | – | 8,112,121 | – | 6.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
| Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
| Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
| Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
| Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
| 683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
| PA Capital LLC | 138,082 | $236,000 | 0.25% |
| ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |